Quantcast

Latest Colon Cancer Stories

2014-02-27 08:28:32

New Ireland PSA Supports March's National Colorectal Cancer Awareness Month DOWNERS GROVE, Ill., Feb. 27, 2014 /PRNewswire-USNewswire/ -- Kathy Ireland is partnering with the American Society for Gastrointestinal Endoscopy (ASGE), which represents the doctors who specialize in endoscopy and colon cancer screening, on a new Public Service Announcement (PSA) to encourage those 50 and over to undergo screening for colon cancer. Colon cancer kills approximately 50,000 people each year,...

2014-02-26 08:25:44

STOP Colon Cancer study addresses disparities among uninsured, low-income and Latino patients PORTLAND, Ore., Feb. 26, 2014 /PRNewswire/ -- Colon cancer screening rates increased by nearly 40 percent when free stool tests were mailed to patients' homes, according to results of a pilot study published today in the journal BMC Cancer. (Logo: http://photos.prnewswire.com/prnh/20130718/SF49717LOGO) The study, funded by the National Institutes of Health, included 869 patients who...

2014-02-25 23:27:02

“It’s important for people to understand that with proper screening, colon cancer can not only be detected early, but often can be prevented from developing,” says Dr. Felice Schnoll-Sussman, a gastroenterologist and director of The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian/Weill Cornell Medical Center. New York, NY (PRWEB) February 25, 2014 March is Colon Cancer Awareness Month. Colon cancer, the second-leading cause of cancer death in the United...

2014-02-20 04:21:29

WHIPPANY, N.J., Feb. 20, 2014 /PRNewswire/ -- Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga(®) (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases. The randomized, double-blind, placebo-controlled Phase III trial is designed to determine the effects of Stivarga as adjuvant treatment following surgical removal of liver metastases.(1) "Patients with more advanced colorectal cancer often...

2014-01-28 12:29:12

Science philanthropist, Jeffrey Epstein and the founder of the Program for Evolutionary Dynamics at Harvard University has helped fund pivotal research in how to combat colon cancer and specifically cancer resistance to inhibitor drugs NEW YORK, Jan. 28, 2014 /PRNewswire/ -- Science philanthropist, Jeffrey Epstein and the founder of the Program for Evolutionary Dynamics at Harvard University has helped fund pivotal research in how to combat colon cancer and specifically cancer...

2013-12-02 09:57:42

Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world. "This is the first step toward clinically applying the principles of cancer stem cell biology to control cancer growth and advance the...

2013-11-21 23:35:01

Despite urging by experts, one third of Americans are still neglecting colonoscopy screenings. Los Angeles, CA (PRWEB) November 21, 2013 Despite its wide availability, many Americans are still neglecting screening colonoscopy (a potentially life-saving colon cancer test) according to a recent Centers for Disease Control (CDC) study. In its report released on November 8, 2013 at its website (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6244a4.htm?s_cid=mm6244a4_w), up to 20 million Americans...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related